News

Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.

Three Motley Fool contributors believe they have

In this video, I will talk about UnitedHealth Group (NYSE: UNH) and explain why the stock has crashed 50% in the past month. Watch the short video to learn more, consider subscribing, and click the

UnitedHealth (NYSE: UNH) made several massive announcements during an investor update that crashed the stock price.

*Stock prices used were the afternoon prices of May 12, 2025. The video was

UnitedHealth (NYSE: UNH) is capturing headlines for all the wrong reasons.

*Stock prices used were the afternoon prices of May 13, 2025. The video was published on May 15, 2025.

Continue reading

So

Looking for income? You might want to check out Pfizer (NYSE: PFE). This big drugmaker has been a favorite for income investors for years. However, its dividend is arguably more attractive than

Healthcare insurance giant UnitedHealth Group (NYSE: UNH) has seen its stock go from a stable stalwart to a falling knife, seemingly overnight. The stock's price crashed 22.4% on April 17 in

Over the past year, America's typically predictable health insurance industry has been exciting in ways that investors hardly appreciate. In a nutshell, healthcare expenses have been outpacing the

Shares of UnitedHealth Group (NYSE: UNH) are falling on Thursday. The company's stock has plummeted 15% as of 11:33 a.m. ET but lost as much as 19.2% earlier in the day. The collapse comes as the

Recently, the Trump Administration signed an executive order to lower the prices Americans pay for prescription drugs. According to the administration, the U.S. funds roughly 75% of global

It's no secret that President Donald Trump is heavily invested in cryptocurrencies ranging from Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) to his Official Trump (CRYPTO: TRUMP) meme coin on

Vertex Pharmaceuticals (NASDAQ: VRTX), a leading drugmaker, is performing exceedingly well for the year -- or at least it was, until it released its first-quarter update. The results were not to the

Monday wasn't a very good day for health insurers, and if a day's not good for health insurers you can bet Cigna Group (NYSE: CI) stock took it on the chin.

The blow came from the highest levels of

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive.

But when a dividend yield

J.P. Morgan stated last month that it believes there is a 60% chance of a recession in 2025 due to trade wars and tariffs. The raging bull market that started at the beginning of 2023 is in

When investing in dividend stocks, paying attention to the right things is essential. A high yield can be attractive, but the most critical factor to consider is a company's underlying operations.

There are a few things that Ford Motor Company (NYSE: F), Target (NYSE: TGT), and Pfizer (NYSE: PFE), have in common. They are all components of the prestigious S&P 500. The stocks all pay a

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past few decades, and that the lion's share of market returns can be

The average stock on the S&P 500 yields just 1.4%. If you invested $54,000 into stocks averaging that kind of a yield, you'd collect just $756 in annual dividend income. But if you invested that

Buying a quality dividend stock near a multiyear low can be a great move, especially if you're willing to be patient and hang on for the long term. As long as the dividend remains intact, the yield

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had been up well over 20% year to date. However, Vertex's shares plunged after

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday

Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) first-quarter financial report.

Vertex's first-quarter financial results didn't keep up with what investors have gotten used to

Any time is a great time to buy stocks -- if you pick the right stocks. That's true even in May, a month where some investors have traditionally opted to take a break from the stock market for the

Investors often view Pharmaceutical stocks as safe havens during periods of market turbulence. Stock market volatility or even economic downturns usually don't affect drugmakers' underlying

Medical device specialist Medtronic (NYSE: MDT) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow